跳转至内容
Merck
CN
  • The chronic lymphocytic leukemia clone disrupts the bone marrow microenvironment.

The chronic lymphocytic leukemia clone disrupts the bone marrow microenvironment.

Stem cells and development (2014-07-24)
Alexandre Janel, Frédérique Dubois-Galopin, Céline Bourgne, Juliette Berger, Karin Tarte, Nathalie Boiret-Dupré, Stéphane Boisgard, Pierre Verrelle, Pierre Déchelotte, Olivier Tournilhac, Marc G Berger
摘要

The systematic localization of chronic lymphocytic leukemia (CLL) B-cells in the bone marrow (BM), together with the ex vivo protective effect of stromal cells on their spontaneous apoptosis, both indicate a specific role of the BM microenvironment. In vivo, the impact of CLL cells on mesenchymal stromal cells (MSCs) remains a source of debate. Here, we quantified and expanded colony forming unit-fibroblasts (CFU-Fs) from CLL-BM under standard conditions, analyzed the expression of selected genes, and studied secretion profiles. We observed failing of CLL-BM cultures in standard conditions (45.5% vs. <0.1%), and even after adding basic fibroblast growth factor (bFGF), there were fewer CFU-F than from normal BM (1.3 vs. 40/10(6) cells respectively; P<0.01). Furthermore, their polygonal aspect and low proliferative capacity, together with the expression of 384 selected genes and a secreted set of molecules related to senescence-associated secretory phenotype indicated a state of senescence, further confirmed by the higher proportion of senescence-associated β-galactosidase (SA-βGAL)-positive cells and p16INK4a overexpression. In our hands, hypoxic conditions (5% O2) did not rescue CFU-Fs. Given the role of MSC in BM tissue organization, we studied hematons that are generally considered to be elementary BM units. These structures were rare or had even disappeared completely. When hematons were present, we systematically observed nodular B-CLL cell invasion only. These data confirm that the B-CLL clone has a marked impact on MSC and disrupts BM organization in vivo, raising new questions about in vivo pathophysiology.

材料
Product Number
品牌
产品描述

Sigma-Aldrich
氢氧化铵 溶液, ACS reagent, 28.0-30.0% NH3 basis
Sigma-Aldrich
氢氧化铵 溶液, 28% NH3 in H2O, ≥99.99% trace metals basis
Sigma-Aldrich
地塞米松, powder, BioReagent, suitable for cell culture, ≥97%
Sigma-Aldrich
L-谷氨酰胺, meets USP testing specifications, suitable for cell culture, 99.0-101.0%, from non-animal source
Sigma-Aldrich
L -抗坏血酸, powder, suitable for cell culture, γ-irradiated
Sigma-Aldrich
L -抗坏血酸, BioXtra, ≥99.0%, crystalline
Sigma-Aldrich
L -抗坏血酸, suitable for cell culture, suitable for plant cell culture, ≥98%
Sigma-Aldrich
氢氧化铵 溶液, puriss., 30-33% NH3 in H2O
Sigma-Aldrich
L -抗坏血酸, 99%
Sigma-Aldrich
L -抗坏血酸, reagent grade, crystalline
Supelco
维生素C, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L-谷氨酰胺, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
亚硒酸钠, 99%
USP
抗坏血酸, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
亚硒酸钠, BioReagent, suitable for cell culture, ≥98%
SAFC
L-谷氨酰胺
Sigma-Aldrich
环丙沙星, ≥98% (HPLC)
Sigma-Aldrich
氢氧化铵 溶液, puriss. p.a., reag. ISO, reag. Ph. Eur., ~25% NH3 basis
Sigma-Aldrich
吲哚美辛, 98.5-100.5% (in accordance with EP)
Sigma-Aldrich
亚硒酸钠, γ-irradiated, lyophilized powder, BioXtra, suitable for cell culture
Sigma-Aldrich
苏木精
Sigma-Aldrich
L -抗坏血酸, ACS reagent, ≥99%
Supelco
L -抗坏血酸, analytical standard
Sigma-Aldrich
L -抗坏血酸, meets USP testing specifications
Sigma-Aldrich
氢氧化铵 溶液, BioUltra, ~1 M NH3 in H2O (T)
Sigma-Aldrich
L -抗坏血酸, reagent grade
Sigma-Aldrich
苏木精, certified by the BSC
Sigma-Aldrich
L-谷氨酰胺, BioUltra, ≥99.5% (NT)
Sigma-Aldrich
氢氧化铵 溶液, puriss., meets analytical specification of Ph. Eur., 25-30% NH3 basis
Sigma-Aldrich
L -抗坏血酸, puriss. p.a., ACS reagent, reag. ISO, Ph. Eur., 99.7-100.5% (oxidimetric)